Saturday , 10 December 2016
Breaking News
Home » Health » Nuclear Medicine Diagnostics Market Outlook, Size, Share and Investment opportunities
Nuclear Medicine Diagnostics Market Outlook, Size, Share and Investment opportunities
Browse And Choose From Our World Class Research Reports

Nuclear Medicine Diagnostics Market Outlook, Size, Share and Investment opportunities

According to the report “Nuclear Medicine Diagnostics Market “, published by Market Data Forecast, the global market is projected to reach USD 18.27 Billion by 2020, at a CAGR of 13.2% from 2015 to 2020.

For full report refer to http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/

Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person’s specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient’s illness. The emerging market will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET

Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/request-sample

Increasing practice of SPECT and PET in medical diagnostics in various geographies, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major driving factors of the market. However, short half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the major restrains for the nuclear medicine market growth.

Global market for Nuclear medicine diagnostics is segmented into two major segments By type (SPECT, PET) and application

By Type

SPECT

  • Technetium-99m (TC-99m)
  • Iodine (I-123)
  • Thallium-201 (TL-201) and
  • Others

PET

  • Rubidium-82 (RB-82),
  • Fluorine-18 and
  • Others

By Application

SPECT

  • lymphoma,
  • cardiology,
  • neurology,
  • thyroid
  • oncology,
  • others

Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

About Market Data Forecast:

Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:

Market Data Forecast, Inc.

Jubilee Gardens,

Hyderabad, India.

+1-888-702-9626 (U.S. TOLL FREE)

contact@marketdataforecast.com

About Lokesh_m

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>